The efficacy of low dose short-term prednisone therapy for remission induction in newly diagnosed rheumatoid arthritis patients

The efficacy of low dose short-term prednisone therapy for remission induction in newly diagnosed rheumatoid arthritis patients

Abstract Background The ACR/EULAR recommendations endorse the use of glucocorticoids (GCs) for rheumatoid arthritis (RA) patients’ flares and as a bridge to a DMARD. However, the recommendation of low dose short-term monotherapy with (GCs) remains open to the discretion of the clinician. The aim of...

Full description

Bibliographic Details
Main Authors: John M. Stacy, Jacob R. Greenmyer, James R. Beal, Abe E. Sahmoun, Erdal Diri
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Advances in Rheumatology
Subjects:
Rheumatoid arthritis
Prednisone
Efficacy
Low dose
Short-term
Remission
Online Access:https://doi.org/10.1186/s42358-021-00205-4

Internet

https://doi.org/10.1186/s42358-021-00205-4

Similar Items